WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 50'9701 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 42'6931 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 34'838  34'487  34'126  33'753  33'370  30'697  27'658  24'511 
Births 391  386  381  375  368  334  387  362 
Surviving infants 389  384  379  373  366  332  385  358 
Pop. less than 5 years 1'967  1'932  1'881  1'845  1'808  1'792  1'929  1'792 
Pop. less than 15 years 5'728  5'675  5'621  5'618  5'627  5'885  5'727  5'581 
Female 15-49 years 8'268  8'289  8'302  8'287  8'259  7'972  7'470  6'540 

Number of reported case

(Click for retrospective incidence data for Canada)
Diphtheria 55 
Japanese encephalitis
Measles 10  759  99  14  62  206  1'033  13'864 
Mumps 54  282  799  214  748  88 
Pertussis 4'845  676  759  1'667  1'961  4'054  8'030  2'873 
Polio*
Rubella 12  28 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Canada)
Vaccine year result method % card seen                                                
BCG         
DTP1          99 
DTP3          95  95  77  80  80 
HepB_BD         
HepB3          70  70  17  17 
Hib3          95  95  77  80  80 
JapEnc         
MCV          98  98  93  93  93 
MCV2          94 
PCV1          98  98  26 
PCV3          97  97  26 
Pol3          99  99  83  80  80 
Rota1         
Rota_last         
Rubella1          98  98  93  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Canada)
DTP1 98  98  98  98  98  97  96 
DTP3 95  95  95  95  94  92  88 
HepB3 70  70  56  42  28 
Hib3 95  95  95  95  94  86 
MCV 98  98  97  96  95  96  89 
PCV3 97  97  97  97  97 
Pol3 99  99  97  95  92  88  88 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG BCG-Infants & children belonging to groups with high rates of infection
DTaPHibHepIPV 2, 4, 6 months;
DTaPHibIPV 2, 4, 6, 18 months;
DTaPIPV 4-6 years; Yes
HPV 1st contact; +2, +6 months; Yes
HepA high risk groups
HepB Early infancy (3 doses) or pre-teen (2-3 doses)
Influenza > 6 months; > 18 years; Yes
MMR 12, 18 months; or 4-6 years; Yes
MenC_conj Yes Infancy (1-4 doses) and pre-teen (1 dose)
Pneumo_conj 2, 4, 6, 12-15 months; Yes
Pneumo_ps >=65 years; Yes
Td every 10 years for those who have completed primary series
Tdap 14-16 years; Yes
Varicella 12 months; 18 months or 4-6 years; Yes Recommended for susceptible older children, adolescents and adults

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes    Yes  Yes     
What years does the MYP cover? number   2004-2009           
Nº of districts with microplans that include activities to raise immunization coverage number 13  13    13       

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number       13  13  13  13 
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR           Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND              

Finance

Percentage of routine vaccines funded by Government From 0 to 100%              

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.